Home » Topics » Regulatory

Regulatory
RSS

European Commission approves retigabine for partial onset seizures

March 31, 2011

BMS' ipilimumab approved in U.S. for unresectable or metastatic melanoma

March 28, 2011

GSK and HGS receive FDA approval for new lupus treatment Benlysta

March 10, 2011

FDA approves Takeda's Edarbi to treat high blood pressure

March 1, 2011

Astellas' Protopic approved in Canada for prevention of eczema flares

Feb. 18, 2011

GSK to launch new alli chewable tablet as weight loss aid

Feb. 9, 2011

Chugai Pharma files for new indication of Pegasys

Jan. 27, 2011

TPIAO approved in China for idiopathic thrombocytopenic purpura

Jan. 26, 2011

FDA approves Viibryd for major depressive disorder

Jan. 25, 2011

New osteoporosis drug Edirol approved in Japan

Jan. 21, 2011

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...